The Fund continues the proven “Project Focused Company” investment strategy for early-stage drug development candidates. In addition, the Fund continues to invest in late-stage clinical …
News
CENTOGENE Announces Leadership Transition
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …
2022 TVM Capital Winter Conference
Dear Friends and Partners of TVM Capital Life Science. In light of the ongoing (COVID-19) coronavirus outbreak and the resulting travel restrictions, we have decided to postpone the TVM Winter …
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …
Centogene öffnet seine Labore für Coronatests
Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spur ist, öffnet seine Labore für lebensrettende Coronatests. Bis zu 10.000 Abstriche können pro Tag …